Janssen Search
Search results
Infectious Diseases & Vaccines
Infectious Diseases & Vaccines Infectious Diseases & Vaccines The structure of HIV Creating Treatments for Infectious Diseases Discovery & Development Global Reach Respiratory Infections Chronic Infections Bacterial Infections Other Focus ...
Najat Khan, Ph.D.
NAJAT KHAN, Ph.D. CHIEF DATA SCIENCE OFFICER GLOBAL HEAD, STRATEGY & OPERATIONS JANSSEN R&D Najat Khan, Ph.D., is the Chief Data Science Officer and the Global Head (Vice President) of Strategy & Operations for Janssen Research & ...
Creating Treatments for Infectious Diseases
Through science and innovation, we aim to protect, save and improve lives from infectious diseases. We’ve got a long history of doing more. From helping change the course of HIV and TB to developing vaccines for Ebola and COVID-19, we have been working ...
R&D Data Science
Data Sciences Data Sciences Overview Machine Learning Artificial Intelligence Machine Based Analytics Computer Vision Real World Data Clinical Design Operations Technology-Enabled Genomics Natural Language Processing Ai Drug Design Generative Modeling ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
PH Development
Development Investing in ways to improve the diagnosis gap and improve survival rates. At Janssen, we are committed to addressing the diagnostic gap and improving survival rates. We have undertaken extensive research to map out the patient journey in ...
Megha Reddy
MEGHA REDDY HEAD OF STRATEGY WORLD WITHOUT DISEASE ACCELERATOR As Head of Strategy for the World Without Disease Accelerator (WWDA), Megha leads the overall WWDA strategic planning, including the development of short- and long-term goals and objectives. ...
Tom Cavanaugh
TOM CAVANAUGH COMPANY GROUP CHAIRMAN NORTH AMERICA Tom Cavanaugh is Company Group Chairman, North America, Tom is a member of the Innovative Medicine Pharmaceuticals Group Operating Committee and responsible for leading our efforts to transform the health ...
Green Chemistry and Technology
Green Chemistry and Technology Our R&D teams continue to integrate principles of green chemistry and engineering to develop our medicines. A few examples include: For application in our late-stage product portfolio, we achieved process intensification ...